{"id":26722,"date":"2020-09-22T07:20:49","date_gmt":"2020-09-22T07:20:49","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=65050"},"modified":"2020-09-22T07:20:49","modified_gmt":"2020-09-22T07:20:49","slug":"tcm-lianhua-qingwen-capsule-approved-for-registration-in-mauritius","status":"publish","type":"post","link":"https:\/\/southafricajournal.com\/tcm-lianhua-qingwen-capsule-approved-for-registration-in-mauritius\/","title":{"rendered":"TCM Lianhua Qingwen Capsule approved for registration in Mauritius"},"content":{"rendered":"
SHIJIAZHUANG, China, Sept. 22, 2020 \/PRNewswire\/ — Yiling Pharmaceutical Co., Ltd. (SHE: 002603) announced on Tuesday that it has received a registration approval issued by the Ministry of Health and Wellness of Mauritius, indicating Lianhua Qingwen Capsule has been registered in accordance with the standards for Chinese Traditional Medicine.<\/p>\n
As a leading product of Yiling Pharmaceutical Co., Ltd., Lianhua Qingwen products are mainly used for the treatment of cold and flu-related diseases, and have been listed in the diagnosis and treatment schemes for cold and flu-related diseases by the National Health Commission of China and National Administration of Traditional Chinese Medicine of China successively for many times. In 2020, Lianhua Qingwen Capsule\u00a0\/ Granule has been listed as a recommended medicine for the epidemic in the Diagnosis and Treatment Scheme of Novel Coronavirus Pneumonia (Versions #4-#8)<\/i>, issued officially by the related Chinese authorities. In April, 2020, the National Medical Products Administration of China approved that a new indication for “mild and common COVID-19” was added to Lianhua Qingwen Capsule on the basis of its originally approved indications.<\/p>\n
Up to now, Lianhua Qingwen Capsule has been approved for launching on the market in nearly 20 countries and regions including Brazil, Philippines, Kuwait, Romania and Thailand.<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"
SHIJIAZHUANG, China, Sept. 22, 2020 \/PRNewswire\/ \u2014 Yiling Pharmaceutical Co., Ltd. (SHE: 002603) announced on Tuesday that it has received a registration approval issued by the Ministry of Health and Wellness of Mauritius, indicating Lianhua Qingwen Capsule has been registered in accordance with the standards for Chinese Traditional Medicine. As a leading product of Yiling [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31],"tags":[],"yoast_head":"\n